Cargando…

Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation

Cystic fibrosis (CF) is a lifelong, inflammatory multi-organ disease and the most common lethal, genetic condition in Caucasian populations, with a median survival rate of 41.5 years. Pulmonary disease, characterized by infective exacerbations, bronchiectasis and increasing airway insufficiency is t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bannon, Aidan, Zhang, Shu-Dong, Schock, Bettina C., Ennis, Madeleine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588248/ https://www.ncbi.nlm.nih.gov/pubmed/25925366 http://dx.doi.org/10.1159/000381423

Ejemplares similares

Toll like Receptor signalling by Prevotella histicola activates alternative NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to P. aeruginosa
por: Bertelsen, Anne, et al.
Publicado: (2020)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

Inhibition of NFκB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation
por: Maitra, Rangan, et al.
Publicado: (2009)

Defective CFTR- β-catenin interaction promotes NF-κB nuclear translocation and intestinal inflammation in cystic fibrosis
por: Liu, Kaisheng, et al.
Publicado: (2016)

Dysregulated apoptosis and NFκB expression in COPD subjects
por: Brown, Vanessa, et al.
Publicado: (2009)

Inflammation in Cystic Fibrosis
Publicado: (1996)

A regulatory SNP modifies cystic fibrosis by disrupting NFκB complex binding on FAS
por: Awah, Chidiebere U, et al.
Publicado: (2015)

Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
por: Zhou, Yifan, et al.
Publicado: (2020)

Infection, inflammation and exercise in cystic fibrosis
por: van de Weert-van Leeuwen, Pauline Barbera, et al.
Publicado: (2013)

Biomarkers of inflammation in infants with cystic fibrosis
por: Laguna, Theresa A., et al.
Publicado: (2018)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Fungal Infection and Inflammation in Cystic Fibrosis
por: Poore, T. Spencer, et al.
Publicado: (2021)

NF-κB signaling in tanycytes mediates inflammation-induced anorexia
por: Böttcher, Mareike, et al.
Publicado: (2020)

NF-κB signaling in inflammation
por: Liu, Ting, et al.
Publicado: (2017)

Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial–mesenchymal transition and inflammation
por: Peng, Ling, et al.
Publicado: (2020)

BEDSIDE INTERPRETATION OF LABORATORY FINDINGS
Publicado: (1932)

Antimicrobial properties of phytohormone (gibberellins) against phytopathogens and clinical pathogens
por: Toner, Paoirse, et al.
Publicado: (2021)

Knockout of the Cannabinoid Receptor 2 Gene Promotes Inflammation and Hepatic Stellate Cell Activation by Promoting A20/Nuclear Factor-κB (NF-κB) Expression in Mice with Carbon Tetrachloride-Induced Liver Fibrosis
por: Long, Cuizhen, et al.
Publicado: (2021)

Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis
por: Quinn, Derek J, et al.
Publicado: (2010)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

Inflammation and Infection in Cystic Fibrosis: Update for the Clinician
por: Petrocheilou, Argyri, et al.
Publicado: (2022)

Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review
por: Martínez-García, Miguel Ángel, et al.
Publicado: (2022)

Targeting GPR65 alleviates hepatic inflammation and fibrosis by suppressing the JNK and NF-κB pathways
por: Zhang, Kun, et al.
Publicado: (2023)

Cystic Diseases of the Kidneys: From Bench to Bedside
por: Raina, Rupesh, et al.
Publicado: (2023)

Zinc Prevents Abdominal Aortic Aneurysm Formation by Induction of A20-Mediated Suppression of NF-κB Pathway
por: Yan, Ya-Wei, et al.
Publicado: (2016)

NF-κB in inflammation and renal diseases
por: Zhang, Haisong, et al.
Publicado: (2015)

NF-κB: At the Borders of Autoimmunity and Inflammation
por: Barnabei, Laura, et al.
Publicado: (2021)

NF‐κB signaling in inflammation and cancer
por: Zhang, Tao, et al.
Publicado: (2021)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
por: Harwood, Kiera H., et al.
Publicado: (2021)

Bedside and laboratory diagnostic testing in myasthenia
por: Yoganathan, Katie, et al.
Publicado: (2022)

A20-binding inhibitor of NF-κB (ABIN) 2 negatively regulates allergic airway inflammation
por: Ventura, Sonia, et al.
Publicado: (2018)

Sappanone a prevents diabetic kidney disease by inhibiting kidney inflammation and fibrosis via the NF-κB signaling pathway
por: Wang, Zhe, et al.
Publicado: (2022)

KLF2 in Regulation of NF-κB-Mediated Immune Cell Function and Inflammation
por: Jha, Prerana, et al.
Publicado: (2017)

Intrapulmonary administration of purified NEIL2 abrogates NF-κB–mediated inflammation
por: Tapryal, Nisha, et al.
Publicado: (2021)

β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction
por: Hu, Shikai, et al.
Publicado: (2021)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis
por: Lee, Jung M., et al.
Publicado: (2012)

The Role of Sphingolipids and Ceramide in Pulmonary Inflammation in Cystic Fibrosis
por: Becker, Katrin Anne, et al.
Publicado: (2010)

Mitochondrial Stress Responses and “Mito-Inflammation” in Cystic Fibrosis
por: Patergnani, Simone, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p47ndehs2i05ep2bk7q1j73kib